7.94
Precedente Chiudi:
$7.71
Aprire:
$7.62
Volume 24 ore:
325.80K
Relative Volume:
2.20
Capitalizzazione di mercato:
$297.02M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
158.80
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
+4.20%
1M Prestazione:
+7.15%
6M Prestazione:
+36.43%
1 anno Prestazione:
+88.15%
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LFCR
Lifecore Biomedical Inc
|
7.94 | 279.06M | 128.45M | 6.54M | -8.79M | 0.05 |
![]()
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-21 | Iniziato | William Blair | Outperform |
2024-09-05 | Iniziato | Craig Hallum | Buy |
2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
What’s next for Lifecore Biomedical Inc. stock price2025 Short Interest & Accurate Buy Signal Notifications - Newser
Detecting price anomalies in Lifecore Biomedical Inc. with AI2025 Geopolitical Influence & Fast Entry Momentum Alerts - Newser
How to monitor Lifecore Biomedical Inc. with trend dashboardsStop Loss & Long-Term Safe Investment Ideas - Newser
Full technical analysis of Lifecore Biomedical Inc. stockJuly 2025 Momentum & Short-Term High Return Strategies - Newser
Exit strategy if you’re trapped in Lifecore Biomedical Inc. - Newser
Will Lifecore Biomedical Inc. stock recover after recent dropQuarterly Trade Report & AI Driven Stock Movement Reports - Newser
Should you wait for a breakout in Lifecore Biomedical Inc.Stop Loss & Growth Focused Stock Pick Reports - Newser
Is Lifecore Biomedical Inc. stock entering bullish territory2025 Major Catalysts & High Yield Equity Trading Tips - Newser
Lifecore Biomedical Inc. stock chart pattern explainedWeekly Volume Report & Community Shared Stock Ideas - Newser
Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewswire
What’s the beta of Lifecore Biomedical Inc. stockJuly 2025 Chart Watch & Real-Time Volume Triggers - khodrobank.com
Lifecore Biomedical to Participate in Investor Conferences - AInvest
CDMO Leader Lifecore Biomedical Announces Triple Conference Schedule Including Morgan Stanley Healthcare - Stock Titan
Does Lifecore Biomedical Inc. stock benefit from AI growthJuly 2025 Update & Safe Capital Growth Stock Tips - khodrobank.com
Published on: 2025-09-02 13:35:37 - Newser
Detecting support and resistance levels for Lifecore Biomedical Inc.Dollar Strength & AI Powered Market Entry Ideas - Newser
What to do if you’re stuck in Lifecore Biomedical Inc.Analyst Upgrade & Proven Capital Preservation Methods - Newser
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What are the risks of holding Lifecore Biomedical Inc.July 2025 Weekly Recap & Entry Point Confirmation Signals - khodrobank.com
Can a trend reversal in Lifecore Biomedical Inc. lead to recoveryMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
What are the future prospects of Lifecore Biomedical Inc.2025 Trading Recap & Stepwise Trade Signal Implementation - khodrobank.com
Will Lifecore Biomedical Inc. benefit from seasonalityPortfolio Return Report & Trade Opportunity Analysis - khodrobank.com
Is Lifecore Biomedical Inc. forming bullish engulfing patternsSell Signal & Consistent Profit Trade Alerts - khodrobank.com
Using RSI to spot recovery in Lifecore Biomedical Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser
Lifecore Biomedical’s (NASDAQ:LFCR) Undervaluation and Growth Potential: A Case for Strategic Investment - AInvest
Using data models to predict Lifecore Biomedical Inc. stock movement2025 Performance Recap & Risk Managed Trade Strategies - Newser
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Intrinsic Value Is Potentially 44% Above Its Share Price - Yahoo Finance
Applying sector rotation models to Lifecore Biomedical Inc.Market Movers & Safe Entry Point Alerts - Newser
How hedge fund analytics apply to Lifecore Biomedical Inc. stockEntry Point & Stepwise Trade Signal Implementation - Newser
Is Lifecore Biomedical Inc. forming a bullish divergenceWeekly Market Report & Stepwise Swing Trade Plans - kpenews.com
Predicting Lifecore Biomedical Inc. trend using moving averages2025 Performance Recap & Technical Pattern Based Signals - Newser
Relative strength of Lifecore Biomedical Inc. in sector analysisJuly 2025 Update & AI Powered Market Entry Strategies - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire
Automated trading signals detected on Lifecore Biomedical Inc.Trade Analysis Summary & Comprehensive Market Scan Insights - Newser
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsMarket Weekly Review & Weekly Top Stock Performers List - Newser
How sentiment analysis helps forecast Lifecore Biomedical Inc.Weekly Trade Analysis & Consistent Profit Trade Alerts - Newser
Is Lifecore Biomedical Inc. stock ready for a breakoutJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifecore Biomedical Inc Azioni (LFCR) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):